I agree with you the press release had no real information to take our share price higher..
It would be nice if Benitec updated the market on our cancer program because it would likely provide new information and let everyone know we are close to a human clinical trial.
BLT Price at posting:
24.0¢ Sentiment: Buy Disclosure: Held